
Investigators at the Royal Marsden Hospital and University College in London have studied thalidomide (Thalomid) as both low-dose (100 mg orally, every night) and high-dose (600 mg, given as 300 mg twice per day)

Your AI-Trained Oncology Knowledge Connection!


Published: December 2nd 2000 | Updated: